AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?

The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to ...

Buried within the One Big Beautiful Bill Act is a provision that could improve or even save the lives of the 30 million ...

Dotmatics, an early research and development company, says they're using AI to help accelerate the timeline in drug discoveries. "The art of drug discovery is really finding drugs in these massive ...

As leaders across the United States consider options to reduce healthcare costs, they must ensure that well-intended reforms ...

Access Transportation Research Board Publications Our peer-reviewed reports present the evidence-based consensus of committees of experts. Published proceedings record the presentations and ...

Access Transportation Research Board Publications Our peer-reviewed reports present the evidence-based consensus of committees of experts. Published proceedings record the presentations and ...

Rdcthera announced today the release of its revolutionary RDC development services aimed at expediting the bioconjugation drug development process. NEW YORK, NY, USA, July 30, 2024 /EINPresswire ...